Next Tsunami of Work Comp Payments Work comp payments may expand greatly because of a California decision awarding death benefits related to a drug overdose.
7 Ways to a Better Work Comp Plan The seven will improve your work comp program with little effort while enhancing workers’ respect for their jobs and increasing cooperation.
IMR Practices May Be Legal, Yet... ...Using IMR to shift costs of treatment away from workers' comp and to the federal government may be a recipe for long-term disaster.
Options to Work Comp: Public Policy Analysis Analysis of the Texas workers' compensation system shows that, as a matter of public policy, "opt-out" programs make sense.
Urine Drug Testing Must Get Smarter The current approach to urine drug testing yields too many false negatives and positives, doing no favors to either workers or employers.
Promoting Peace of Mind in Work Comp By Barry Thompson To provide peace of mind to an injured worker -- and reduce the number of big claims -- employers should address 10 questions right away.
Stop Being Clueless About Workers' Comp By Rebecca Shafer Clueless employers don't understand that they can control their workers' comp costs -- and not just complain about them.
9 Key Factors for Drug Formularies By Mark Pew Drug formularies should be all about better outcomes for patients, not cost. Take care of the injured worker, and everyone else wins, too.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.